NCT02054325View on ClinicalTrials.gov

Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Varicose Veins
Interventions
DRUG

Polidocanol with Glucose

An application session 0.2% Polidocanol + 70% Glucose to treat reticular veins of the lower limb selected, with a maximum volume of 5 ml. Return to a week to investigate the adverse effects and 2 months for proof of efficacy and adverse effects

DRUG

Glucose

An application session 75% Glucose to treat reticular veins of the lower limb selected, with a maximum volume of 5 ml. Return to a week to investigate the adverse effects and 2 months for proof of efficacy and adverse effects

Trial Locations (1)

18607030

School of Medicine at Botucatu- Paulista State University- UNESP, São Paulo, Brazil, Botucatu

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

UPECLIN HC FM Botucatu Unesp

OTHER

NCT02054325 - Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins | Biotech Hunter | Biotech Hunter